FDA 483 - Children's National Medical Center IRB - June 06, 2019

The FDA inspected Children's National Medical Center IRB and found significant deficiencies in their operations. The IRB failed to promptly report instances of serious non-compliance and study suspensions to the FDA. Additionally, the IRB did not consistently meet quorum requirements for convened meetings and failed to maintain accurate and complete membership rosters.